Ruđer Bošković Institute, Department of Molecular Biology, Zagreb, Croatia.
Department of Neurosurgery, Dubrava University Hospital, Zagreb, Croatia.
Neuroscience. 2018 Nov 10;392:164-171. doi: 10.1016/j.neuroscience.2018.09.029. Epub 2018 Sep 29.
Intracranial hypertension, which often follows a severe brain injury, is usually treated with intravenous (i.v.) application of hyperosmolar solutions. The mechanism of intracranial cerebrospinal fluid (CSF) pressure decrease after such a treatment is still unclear. The aim of this article was to try to explain the mechanism of CSF pressure reduction after i.v. hyperosmolar mannitol bolus in regard to the changes in CSF volume. Two types of experiments were done on anesthetized cats before and after hyperosmolar mannitol application: ventriculo-cisternal perfusion at different perfusion rates, simultaneously measuring the perfusate outflow volume, and CSF pressure recording in the lateral ventricle before and during artificial CSF infusion. Mannitol application in the first group of cats significantly reduced collected prefusate volume during ventriculo-cisternal perfusion, and in the second group it prevented CSF pressure increase caused by artificial CSF infusion. Our results strongly suggest that the mechanism of hyperosmolar mannitol action after its i.v. application is based on osmotic fluid retrieval from interstitial and cerebrospinal compartments into the microvessels. This shift, without significant volume change inside the cranium, causes a predominant decrease of CSF volume in the spinal part of the system, which in turn leads to lowering of the CSF pressure. Spinal CSF volume decrease is enabled by the extensibility of the spinal dura, this way providing the possibility for CSF volume redistribution inside the CSF system, together with CSF pressure decrease. This mechanism of mannitol action is in accordance with the new hypothesis of CSF physiology.
颅内高压常继发于严重的脑损伤,通常采用静脉(i.v.)应用高渗溶液进行治疗。这种治疗后颅内脑脊液(CSF)压力降低的机制仍不清楚。本文的目的是尝试解释静脉高渗甘露醇推注后 CSF 压力降低的机制,特别是与 CSF 体积变化有关的机制。在高渗甘露醇应用前后,对麻醉猫进行了两种类型的实验:在不同灌注速度下进行脑室-蛛网膜下腔灌注,同时测量灌流流出量和侧脑室在人工 CSF 输注前后的 CSF 压力记录。在第一组猫中,甘露醇的应用显著减少了脑室-蛛网膜下腔灌注时收集的 prefusate 体积,而在第二组中,甘露醇防止了人工 CSF 输注引起的 CSF 压力升高。我们的结果强烈表明,静脉应用高渗甘露醇后的作用机制是基于从间质和脑脊液腔室向微血管中回收渗透液。这种转移,在颅腔内没有明显的体积变化,导致系统的脊髓部分 CSF 体积明显减少,从而导致 CSF 压力降低。脊髓 CSF 体积的减少是由脊髓硬脑膜的可扩展性实现的,这样就提供了 CSF 系统内 CSF 体积重新分布的可能性,同时降低了 CSF 压力。甘露醇的这种作用机制与 CSF 生理学的新假说一致。